Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $7.40 billion. The enterprise value is $8.97 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Jun 22, 2026 |
Share Statistics
Bruker has 152.23 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 152.23M |
| Shares Outstanding | 152.23M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 31.89% |
| Owned by Institutions (%) | 91.91% |
| Float | 103.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.78 |
| PS Ratio | 2.14 |
| Forward PS | 2.01 |
| PB Ratio | 3.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 144.27 |
| P/OCF Ratio | 52.75 |
| PEG Ratio | 1.48 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 18.36, with an EV/FCF ratio of 174.91.
| EV / Earnings | n/a |
| EV / Sales | 2.59 |
| EV / EBITDA | 18.36 |
| EV / EBIT | 34.44 |
| EV / FCF | 174.91 |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.55 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 3.13 |
| Debt / FCF | 33.24 |
| Interest Coverage | 4.39 |
Financial Efficiency
Return on equity (ROE) is -0.43% and return on invested capital (ROIC) is -4.29%.
| Return on Equity (ROE) | -0.43% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | -4.29% |
| Return on Capital Employed (ROCE) | 5.45% |
| Weighted Average Cost of Capital (WACC) | 8.02% |
| Revenue Per Employee | $311,998 |
| Profits Per Employee | -$3,284 |
| Employee Count | 11,085 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, Bruker has paid $23.10 million in taxes.
| Income Tax | 23.10M |
| Effective Tax Rate | 168.61% |
Stock Price Statistics
The stock price has increased by +36.96% in the last 52 weeks. The beta is 1.12, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | +36.96% |
| 50-Day Moving Average | 39.05 |
| 200-Day Moving Average | 40.00 |
| Relative Strength Index (RSI) | 73.37 |
| Average Volume (20 Days) | 2,442,612 |
Short Selling Information
The latest short interest is 12.83 million, so 8.43% of the outstanding shares have been sold short.
| Short Interest | 12.83M |
| Short Previous Month | 12.72M |
| Short % of Shares Out | 8.43% |
| Short % of Float | 12.39% |
| Short Ratio (days to cover) | 6.78 |
Income Statement
In the last 12 months, Bruker had revenue of $3.46 billion and -$36.40 million in losses. Loss per share was -$0.24.
| Revenue | 3.46B |
| Gross Profit | 1.65B |
| Operating Income | 260.50M |
| Pretax Income | 13.70M |
| Net Income | -36.40M |
| EBITDA | 488.70M |
| EBIT | 260.50M |
| Loss Per Share | -$0.24 |
Full Income StatementBalance Sheet
The company has $133.40 million in cash and $1.71 billion in debt, with a net cash position of -$1.57 billion or -$10.32 per share.
| Cash & Cash Equivalents | 133.40M |
| Total Debt | 1.71B |
| Net Cash | -1.57B |
| Net Cash Per Share | -$10.32 |
| Equity (Book Value) | 2.50B |
| Book Value Per Share | 16.09 |
| Working Capital | 748.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $140.30 million and capital expenditures -$89.00 million, giving a free cash flow of $51.30 million.
| Operating Cash Flow | 140.30M |
| Capital Expenditures | -89.00M |
| Depreciation & Amortization | 228.20M |
| Net Borrowing | -639.80M |
| Free Cash Flow | 51.30M |
| FCF Per Share | $0.34 |
Full Cash Flow StatementMargins
Gross margin is 47.62%, with operating and profit margins of 7.53% and -0.34%.
| Gross Margin | 47.62% |
| Operating Margin | 7.53% |
| Pretax Margin | 0.40% |
| Profit Margin | -0.34% |
| EBITDA Margin | 14.13% |
| EBIT Margin | 7.53% |
| FCF Margin | 1.48% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -0.49% |
| FCF Yield | 0.69% |
Dividend DetailsAnalyst Forecast
The average price target for Bruker is $49.15, which is 1.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $49.15 |
| Price Target Difference | 1.09% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 4.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.38 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.38 |
| Piotroski F-Score | 4 |
